Back

Acute and long-term lesion durability and reconnection patterns following hybrid atrial fibrillation ablation

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 2 Rhythm Control, Hybrid Therapy EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sahar Mouram

University Hospital (UZ) Brussels, Brussels (Belgium)

8 More presentations in this session

Presentation thumbnail
Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.
Ms C. van der Heijden (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes in hybrid versus standalone thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.
Miss L. Aerts (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Intra-procedural three-dimensional rotational angiography in cryoballoon ablation of atrial fibrillation - results from a randomised clinical trial
Doctor I. Prepolec (Zagreb, HR)
Abstract Slides Video
Presentation thumbnail
The hybrid ablation approach to treating long-standing persistent atrial fibrillation: real-world data from a tertiary institution
Doctor V. Lim (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial
Doctor I. Romanazzi (Bari, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 2

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Clinical findings from a large endo-epicardial atrial arrhythmia ablation registry
thumbnail
Congress Presentation
Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.
thumbnail
Congress Presentation
Two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF: mid-term results of the CEASE-AF trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources